CRBP
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.08
−3.32%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-99.7%
Return on equity
-80.2%
Return on assets
-100.4%
Return on invested capital
0.00x
Asset turnover
-$86.7M
Cash from operations
$6.10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026